Macalalad, Alexander R <br/><br/>
The epidemiology and targeted therapies for relapsed and refractory CD30+ lymphomas.  [electronic resource] 

 -  Current medical research and opinion  Mar 2015 
 - 537-45 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1473-4877 
<br/><br/><label>Standard No.: </label>10.1185/03007995.2015.1008131  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Antineoplastic Agents--therapeutic use<br/>Brentuximab Vedotin<br/>Disease Management<br/>Disease Progression<br/>Hodgkin Disease--epidemiology<br/>Humans<br/>Immunoconjugates--therapeutic use<br/>Ki-1 Antigen--metabolism<br/>Lymphoma, Large-Cell, Anaplastic--epidemiology<br/>Molecular Targeted Therapy--methods<br/>Recurrence<br/>Sex Factors<br/>Treatment Outcome